- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
United Therapeutics Corp+ Add to Watchlist
UTHR:US130.2200 USD 2.4000 1.88%
As of 17:10:00 ET on 12/24/2014.
Company Profile for United Therapeutics Corp (UTHR)
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.
United Therapeutics Corp
Key Executives for United Therapeutics Corp (UTHR)
|Martine A RothblattChairman/CEO/Founder||Roger A JeffsPresident/COO|
|John M FerrariCFO/Treasurer||Shola OyewoleChief Information Officer|
|David ZaccardelliChief Manufacturing Officer||Paul A MahonExec VP/Secy/General Counsel|